Stock listing
BOATS:REVB Revelation Biosciences, Inc. Stock
US listing (BOATS) of Revelation Biosciences, Inc. · home listing NASDAQ:REVB
Follow Revelation Biosciences, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:REVB
$4.05 USD +0.02 (+0.5%)
Close on Nov 2, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:REVB
- Day range
- $3.86 – $4.13 USDNov 2, 2026
- Volume
- 9,558 sharesNov 2, 2026
- Market cap
- $2.30M USDAt the close on Nov 2, 2026 · price × 569,059 shares outstanding
- 52-week range
- $3.08 – $40.60 USDLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
- Traded on an average day
- $52,128 USDMedian day 4,483 shares · last 3 months, Aug 3, 2026 – Nov 2, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:REVB · Home | $4.05 USD | +0.02 (+0.5%) | 9,558 | $4.00 | $4.133 | $3.86 | $4.03 | Close on Nov 2, 2026 |
Daily closes
Last 3 months, Aug 3, 2026 – Nov 2, 2026 · NASDAQ:REVB · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $4.05 | +0.02 | +0.5% | $4.00 | $4.133 | $3.86 | 9,558 | |
| $4.03 | +0.28 | +7.5% | $3.79 | $4.03 | $3.75 | 22,064 | |
| $3.75 | +0.03 | +0.8% | $3.63 | $3.75 | $3.56 | 4,981 | |
| $3.72 | -0.01 | -0.3% | $3.76 | $3.84 | $3.72 | 9,021 | |
| $3.73 | +0.195 | +5.5% | $3.437 | $3.73 | $3.437 | 14,686 | |
| $3.535 | -0.255 | -6.7% | $3.80 | $3.87 | $3.36 | 10,746 | |
| $3.79 | +0.11 | +3.0% | $3.68 | $3.88 | $3.66 | 16,300 | |
| $3.68 | +0.08 | +2.2% | $3.67 | $3.85 | $3.601 | 35,500 | |
| $3.60 | -0.15 | -4.0% | $3.75 | $3.97 | $3.51 | 19,500 | |
| $3.75 | +0.467 | +14.2% | $3.30 | $4.06 | $3.294 | 156,000 | |
| $3.283 | -0.112 | -3.3% | $3.50 | $3.57 | $3.08 | 43,643 | |
| $3.395 | -1.94 | -36.4% | $4.935 | $4.935 | $3.269 | 90,743 | |
| $5.335 | +0.297 | +5.9% | $5.215 | $5.459 | $5.11 | 2,949 | |
| $5.038 | -0.073 | -1.4% | $5.111 | $5.354 | $4.97 | 3,253 | |
| $5.111 | -0.312 | -5.7% | $5.32 | $5.39 | $5.111 | 3,832 | |
| $5.423 | +0.104 | +1.9% | $5.594 | $5.594 | $5.39 | 1,796 | |
| $5.319 | -0.098 | -1.8% | $5.401 | $5.716 | $5.25 | 3,542 | |
| $5.417 | -0.379 | -6.5% | $5.67 | $5.67 | $5.39 | 9,510 | |
| $5.797 | +0.531 | +10.1% | $5.285 | $5.855 | $5.285 | 7,284 | |
| $5.265 | -0.174 | -3.2% | $5.558 | $5.579 | $5.25 | 4,961 | |
| $5.44 | +0.095 | +1.8% | $5.537 | $5.81 | $5.327 | 12,947 | |
| $5.345 | -0.262 | -4.7% | $5.67 | $5.67 | $5.345 | 6,271 | |
| $5.607 | -0.112 | -2.0% | $5.741 | $5.852 | $5.53 | 8,687 | |
| $5.719 | +0.021 | +0.4% | $5.781 | $5.915 | $5.717 | 4,309 | |
| $5.698 | -0.317 | -5.3% | $6.152 | $6.152 | $5.679 | 7,567 | |
| $6.015 | -0.076 | -1.3% | $6.16 | $6.195 | $5.81 | 4,903 | |
| $6.091 | 0.00 | 0.0% | $6.231 | $6.364 | $5.951 | 6,199 | |
| $6.091 | -0.449 | -6.9% | $6.44 | $6.564 | $6.019 | 10,798 | |
| $6.541 | -0.319 | -4.7% | $6.761 | $6.852 | $6.44 | 8,388 | |
| $6.86 | +0.026 | +0.4% | $7.00 | $7.14 | $6.712 | 4,134 | |
| $6.834 | +0.321 | +4.9% | $6.79 | $7.069 | $6.511 | 2,597 | |
| $6.513 | -0.137 | -2.1% | $6.848 | $6.892 | $6.513 | 2,258 | |
| $6.65 | +0.21 | +3.3% | $6.475 | $6.79 | $6.44 | 4,222 | |
| $6.44 | +0.067 | +1.1% | $6.782 | $6.782 | $6.432 | 2,232 | |
| $6.373 | -0.314 | -4.7% | $6.894 | $6.894 | $6.37 | 5,231 | |
| $6.686 | -0.26 | -3.7% | $6.93 | $6.93 | $6.686 | 2,103 | |
| $6.947 | -0.049 | -0.7% | $6.997 | $7.00 | $6.931 | 517 | |
| $6.996 | -0.074 | -1.0% | $7.00 | $7.00 | $6.996 | 703 | |
| $7.07 | 0.00 | 0.0% | $7.14 | $7.14 | $7.036 | 372 | |
| $7.07 | 0.00 | 0.0% | $7.00 | $7.28 | $7.00 | 2,287 | |
| $7.07 | 0.00 | 0.0% | $7.105 | $7.28 | $6.93 | 1,105 | |
| $7.07 | +0.07 | +1.0% | $7.21 | $7.28 | $6.93 | 2,851 | |
| $7.00 | +0.094 | +1.4% | $6.93 | $7.28 | $6.93 | 2,571 | |
| $6.906 | -0.094 | -1.3% | $7.076 | $7.23 | $6.876 | 3,602 | |
| $7.00 | -0.35 | -4.8% | $7.42 | $7.42 | $7.00 | 1,842 | |
| $7.35 | +0.14 | +1.9% | $7.28 | $7.56 | $7.001 | 2,901 | |
| $7.21 | +0.525 | +7.9% | $6.803 | $7.21 | $6.686 | 2,996 | |
| $6.685 | -0.315 | -4.5% | $6.861 | $7.07 | $6.65 | 5,226 | |
| $7.00 | -0.70 | -9.1% | $7.63 | $7.70 | $6.37 | 28,580 | |
| $7.70 | +0.07 | +0.9% | $7.70 | $7.84 | $7.423 | 7,101 | |
| $7.63 | +0.14 | +1.9% | $7.70 | $7.70 | $7.42 | 1,294 | |
| $7.49 | -0.28 | -3.6% | $7.84 | $7.98 | $7.49 | 3,168 | |
| $7.77 | 0.00 | 0.0% | $8.12 | $8.40 | $7.63 | 23,781 | |
| $7.77 | -0.28 | -3.5% | $8.015 | $8.12 | $7.49 | 10,856 | |
| $8.05 | +0.707 | +9.6% | $7.63 | $8.05 | $7.35 | 9,562 | |
| $7.343 | -0.427 | -5.5% | $7.98 | $7.98 | $7.237 | 4,483 | |
| $7.77 | 0.00 | 0.0% | $7.77 | $7.84 | $7.70 | 1,155 | |
| $7.77 | -0.14 | -1.8% | $7.70 | $7.875 | $7.70 | 660 | |
| $7.91 | 0.00 | 0.0% | $8.015 | $8.015 | $7.70 | 2,174 | |
| $7.91 | -0.07 | -0.9% | $8.26 | $8.521 | $7.84 | 4,933 | |
| $7.98 | +0.14 | +1.8% | $7.21 | $8.40 | $7.21 | 3,653 | |
| $7.84 | -0.21 | -2.6% | $7.91 | $8.065 | $7.84 | 865 | |
| $8.05 | +0.14 | +1.8% | $7.98 | $8.263 | $7.875 | 3,239 | |
| $7.91 | +0.77 | +10.8% | $7.49 | $8.05 | $7.316 | 4,812 | |
| $7.14 | +0.49 | +7.4% | $6.983 | $7.203 | $6.825 | 4,333 |
- Ticker
- BOATS:REVB
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- BOATS
- Currency
- USD
What changed lately
Latest news release · Oct 16, 2026
Revelation Biosciences Announces 1-for-7 Reverse Stock Split Effective October 20, 2026
Latest deck · Jun 1, 2026
Investor Presentation (June 2026)
Investor deck · 19 slides
Latest news
Revelation Biosciences Announces 1-for-7 Reverse Stock Split Effective October 20, 2026
Oct 16, 2026
Closed $3.40 (-36.4%) on Oct 16, 2026
Revelation Biosciences Selects Avance Clinical as CRO for Phase 2/3 TITAN Study
Aug 19, 2026
Closed $7.77 (0.0%) on Aug 19, 2026
Revelation Biosciences, Inc. Announces Financial Results for the Three and Six Months Ended June 30, 2026
Aug 6, 2026
Closed $7.98 (+1.8%) on Aug 7, 2026
Independent Market Assessment Results Show $94 Billion Total Addressable Market for Gemini in Stage 2 and Stage 3 Acute Kidney Injury
Aug 3, 2026
Closed $7.14 (+7.4%) on Aug 3, 2026
Revelation Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jul 21, 2026
Closed $8.05 (0.0%) on Jul 22, 2026
Revelation Biosciences Announces Adoption of Stockholder Rights Plan
Jul 10, 2026
Closed $6.91 (-1.3%) on Jul 13, 2026
Revelation Biosciences Expands Acute Kidney Injury Advisory Board
Jun 1, 2026
Closed $7.63 (-0.5%) on Jun 1, 2026
Revelation Biosciences, Inc. Releases Corporate Update Letter to Stockholders
May 11, 2026
Closed $6.85 (+1.9%) on May 11, 2026
Revelation Biosciences, Inc. Announces Financial Results For the Three Months Ended March 31, 2026
May 7, 2026
Closed $6.72 (-5.9%) on May 8, 2026
Revelation Biosciences Announces Formation of Acute Kidney Injury Advisory Board
Apr 6, 2026
Closed $8.12 (-7.2%) on Apr 6, 2026
Decks
Investor Presentation (June 2026)
Investor deck · 19 slides · Jun 1, 2026
Investor Presentation (June 2026)
Investor deck · 23 slides · June 2026
Investor Presentation (February 2026)
Investor deck · 28 slides · Feb 26, 2026
Technical Presentation (September 2025)
Technical · 26 slides · Sep 9, 2025
Revelation Biosciences, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 22 in the last 12 months · 52 in all · newest Oct 16, 2026 · oldest 2021
- Decks
- 17 decks · latest Jun 1, 2026
Where Revelation Biosciences, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:REVB · Home listing | NASDAQ | United States | USD |
| BOATS:REVB · This page | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Revelation Biosciences, Inc.